Indocyanine green clearance as an outcome prediction tool in cardiac surgery: A prospective study

Journal of Critical Care

Volumn 29, Issue 2, 2014, Pages 224-229

  Weis, Florian ^a   Kilger, Erich ^a   Beiras Fernandez, Andres ^b   Hinske, Christian L ^a   Nassau, Kirsten ^a   Adnan, Lahib ^a   Vicol, Calin ^a   Kur, Felix ^a   Möhnle, Patrick ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Adverse outcome; Cardiac surgery; Hepatic dysfunction; Indocyanine green clearance

Indexed keywords

BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; INDOCYANINE GREEN; COLORING AGENT;

AGE; AGED; ARTICLE; BIOSENSOR; CORONARY ARTERY BYPASS SURGERY; EUROSCORE; FEMALE; HEART FUNCTION; HEART SURGERY; HEART VALVE SURGERY; HEMODIALYSIS; HEMOFILTRATION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PLASMA CLEARANCE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; ADULT; CORONARY ARTERY BYPASS GRAFT; CORONARY CARE UNIT; HEART VALVE; MIDDLE AGED; SURGERY; TIME; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; COLORING AGENTS; CORONARY ARTERY BYPASS; CORONARY CARE UNITS; FEMALE; HEART VALVES; HUMANS; INDOCYANINE GREEN; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84896703923     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.10.023     Document Type: Article

References (32)

1. Möhnle P., Kilger E., Adnan L., Beiras-Fernandez A., Vicol C., Weis F. Indocyanine green clearance after cardiac surgery: the impact of cardiopulmonary bypass. Perfusion 2012, 27:292-299.
2. Brown P.P., Kugelmass A.D., Cohen D.J., Reynolds M.R., Culler S.D., Dee A.D., et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg 2008, 85:1980-1986.
3. Geissler H.J., Hölzl P., Marohl S., Kuhn-Régnier F., Mehlhorn U., Südkamp M., et al. Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg 2000, 17:400-406.
4. Janssen D. Preoperative prediction of prolonged stay in the intensive care unit for coronary bypass surgery. Eur J Cardiothorac Surg 2004, 25:203-207.
5. Nilsson J., Algotsson L., Höglund P., Lührs C., Brandt J. Early mortality in coronary bypass surgery: the EuroSCORE versus The Society of Thoracic Surgeons risk algorithm. Ann Thorac Surg 2004, 77:1235-1239. [discussion1239-40].
6. Ghotkar S.V., Grayson A.D., Fabri B.M., Dihmis W.C., Pullan D.M. Preoperative calculation of risk for prolonged intensive care unit stay following coronary artery bypass grafting. J Cardiothorac Surg 2006, 1:14.
7. Roques F., Michel P., Goldstone A.R., Nashef S.A.M. The logistic EuroSCORE. Eur Heart J 2003, 24:881-882.
8. Nashef S.A.M., Roques F., Hammill B.G., Peterson E.D., Michel P., Grover F.L., et al. Validation of european system for cardiac operative risk evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002, 22:101-105.
9. Hessel E.A. Abdominal organ injury after cardiac surgery. Semin Cardiothorac Vasc Anesth 2004, 8:243-263.
10. Kumle B., Boldt J., Suttner S.W., Piper S.N., Lehmann A., Blome M. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg 2003, 75:1558-1564.
11. Mathie R.T. Hepatic blood flow during cardiopulmonary bypass. Crit Care Med 1993, 21:S72-S76.
12. Mathie R.T., Ohri S.K., Batten J.J., Peters A.M., Keogh B.E. Hepatic blood flow during cardiopulmonary bypass operations: the effect of temperature and pulsatility. J Thorac Cardiovasc Surg 1997, 114:292-293.
13. Raman J.S., Kochi K., Morimatsu H., Buxton B., Bellomo R. Severe ischemic early liver injury after cardiac surgery. Ann Thorac Surg 2002, 74:1601-1606.
14. Sander M., Spies C.D., Foer A., Syn D.-Y., Grubitzsch H., Heymann Von C. Peri-operative plasma disappearance rate of indocyanine green after coronary artery bypass surgery. Cardiovasc J Afr 2007, 18:375-379.
15. Sander M., Spies C.D., Berger K., Schröder T., Grubitzsch H., Wernecke K.D., et al. Perioperative indocyanine green clearance is predictive for prolonged intensive care unit stay after coronary artery bypass grafting-an observational study. Crit Care 2009, 13:R149.
16. Ascione R., Talpahewa S., Rajakaruna C., Reeves B.C., Lovell A.T., Cohen A., et al. Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg 2006, 81:97-103.
17. Michalopoulos A., Alivizatos P., Geroulanos S. Hepatic dysfunction following cardiac surgery: determinants and consequences. Hepatogastroenterology 1997, 44:779-783.
18. Autschbach R., Falk V., Lange H., Oellerich M., Walther T., Mohr F.W., et al. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass. Thorac Cardiovasc Surg 1996, 44:76-80.
19. Chetty G., Sharpe D.A.C., Nandi J., Butler S.J., Mitchell I.M. Liver blood flow during cardiac surgery. Perfusion 2004, 19:153-156.
20. Cherrick G.R., Stein S.W., Leevy C.M., Davidson C.S. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960, 39:592-600.
21. Sakka S.G., Koeck H., Meier-Hellmann A. Measurement of indocyanine green plasma disappearance rate by two different dosages. Intensive Care Med 2004, 30:506-509.
22. Sakka S.G., Reinhart K., Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002, 122:1715-1720.
23. Kimura S., Yoshioka T., Shibuya M., Sakano T., Tanaka R., Matsuyama S. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 2001, 29:1159-1163.
24. Inal M.T., Memiş D., Kargi M., Sut N. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients. J Crit Care 2009, 24:329-334.
25. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
26. Podgorelec V., Kokol P., Stiglic B., Rozman I. Decision trees: an overview and their use in medicine. J Med Syst 2002, 26:445-463.
27. Ibrahim N.A., Kudus A. Decision Tree for Prognostic Classification of Multivariate Survival Data and Competing Risks. Recent Advances in Technologies 2009, ISBN: 978-953-307-017-9, InTech:1-34. M.A. Strangio (Ed.).
28. Dantzker D.R. The gastrointestinal tract. The canary of the body?. JAMA 1993, 270:1247-1248.
29. Meier-Hellmann A., Reinhart K., Bredle D.L., Sakka S.G. Therapeutic options for the treatment of impaired gut function. J Am Soc Nephrol 2001, 12(Suppl 17):S65-S69.
30. Sakka S.G., Thümer O., van Hout N. Indozyaningrün-Plasmaverschwinderate. Intensivmedizin und Notfallmedizin 2010, 47:381-386.
31. Barili F., Pacini D., Capo A., Rasovic O., Grossi C., Alamanni F., et al. Does EuroSCORE II perform better than its original versions? A multicentre validation study. Eur Heart J 2013, 34:22-29.
32. Loef B.G., Epema A.H., Smilde T.D., Henning R.H., Ebels T., Navis G., et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 2005, 16(1):195-200.